Furthermore, in comparative studies, SST analogues, namely AN-162 with cytotoxic effect, exhibit a higher degree of tumour growth inhibition in comparison to doxorubicin alone in triple-negative breast cancer expressing SSTR subtypes [222]. The gene discussed is SST; the disease is neoplasm.